Exact Mass: 279.06775880000004
Exact Mass Matches: 279.06775880000004
Found 410 metabolites which its exact mass value is equals to given mass value 279.06775880000004,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Dibenz[a,j]acridine
D009676 - Noxae > D002273 - Carcinogens CONFIDENCE standard compound; INTERNAL_ID 8309 CONFIDENCE standard compound; INTERNAL_ID 8180
Dibenz(a,h)acridine
D009676 - Noxae > D002273 - Carcinogens CONFIDENCE standard compound; INTERNAL_ID 8267
Thiamin acetic acid
A monocarboxylic acid that is thiamine(1+) which carries an oxo group at position 2.
Cidofovir
Cidofovir is only found in individuals that have used or taken this drug. It is an injectable antiviral medication for the treatment of cytomegalovirus (CMV) retinitis in patients with AIDS. It suppresses CMV replication by selective inhibition of viral DNA synthesis. [Wikipedia]Cidofovir acts through the selective inhibition of viral DNA polymerase.Biochemical data support selective inhibition of CMV DNA polymerase by cidofovir diphosphate, the active intracellular metabolite of cidofovir. Cidofovir diphosphate inhibits herpesvirus polymerases at concentrations that are 8- to 600-fold lower than those needed to inhibit human cellular DNA polymerase alpha, beta, and gamma(1,2,3). Incorporation of cidofovir into the growing viral DNA chain results in reductions in the rate of viral DNA synthesis. J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals > J05AB - Nucleosides and nucleotides excl. reverse transcriptase inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents C471 - Enzyme Inhibitor > C29575 - DNA Polymerase Inhibitor C254 - Anti-Infective Agent > C281 - Antiviral Agent D004791 - Enzyme Inhibitors
Graveoline
Graveoline is found in herbs and spices. Graveoline is an alkaloid from Ruta graveolens (rue). Alkaloid from Ruta graveolens (rue). Graveoline is found in herbs and spices. Graveoline (Rutamine) is an anti-cancer agent that can trigger apoptosis and autophagy in skin melanoma cells. Graveoline also exhibits antifungal activity[1]. Graveoline (Rutamine) is an anti-cancer agent that can trigger apoptosis and autophagy in skin melanoma cells. Graveoline also exhibits antifungal activity[1].
tolmetin sodium
C15H14NNaO3 (279.08713339999997)
D018501 - Antirheumatic Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D016861 - Cyclooxygenase Inhibitors D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D004791 - Enzyme Inhibitors
Graveoline
D011838 - Radiation-Sensitizing Agents > D017319 - Photosensitizing Agents > D011564 - Furocoumarins Graveoline (Rutamine) is an anti-cancer agent that can trigger apoptosis and autophagy in skin melanoma cells. Graveoline also exhibits antifungal activity[1]. Graveoline (Rutamine) is an anti-cancer agent that can trigger apoptosis and autophagy in skin melanoma cells. Graveoline also exhibits antifungal activity[1].
Niazirin
Niazirin is a nitrile glycoside that has been isolated from the leaves of Moringa oleifera (horseradish tree). Niazirin is found in brassicas. Constituent of the leaves of the horseradish tree (Moringa oleifera, Moringaceae). Niazirin is found in brassicas.
N-[4'-hydroxy-(E)-cinnamoyl]-L-aspartic acid
N-[4-hydroxy-(E)-cinnamoyl]-L-aspartic acid is a cocoa metabolite from gut microflora. It is found n urine. Constituent of Arabidopsis thalianaand is also found in roasted cocoa beans and coffee powder [CCD].
Avenalumin II
Phytoalexin from oat (Avena sativa) infected with rust fungus Puccinia coronata. Avenalumin II is found in oat and cereals and cereal products. Avenalumin II is found in cereals and cereal products. Phytoalexin from oat (Avena sativa) infected with rust fungus Puccinia coronata.
Graveolinine
Graveolinine is found in herbs and spices. Graveolinine is an alkaloid of Ruta graveolens (rue
7-Hydroxyticlopidine
7-Hydroxyticlopidine is a metabolite of Ticlopidine. 7-Hydroxyticlopidine belongs to the family of Thienopyridines. These are heterocyclic compounds containing a thiophene ring fused to a pyridine ring.
2-Oxoticlopidine
2-Oxoticlopidine is only found in individuals that have used or taken Ticlopidine. 2-Oxoticlopidine is a metabolite of Ticlopidine. 2-oxoticlopidine belongs to the family of Thienopyridines. These are heterocyclic compounds containing a thiophene ring fused to a pyridine ring.
Ticlopidine S-oxide
Ticlopidine S-oxide is only found in individuals that have used or taken Ticlopidine. Ticlopidine S-oxide is a metabolite of Ticlopidine. Ticlopidine s-oxide belongs to the family of Thienopyridines. These are heterocyclic compounds containing a thiophene ring fused to a pyridine ring.
Ticlopidine N-oxide
Ticlopidine N-oxide is a metabolite of ticlopidine. Ticlopidine (trade name Ticlid) is an antiplatelet drug in the thienopyridine family. Like clopidogrel, it is an adenosine diphosphate (ADP) receptor inhibitor. It is used in patients in whom aspirin is not tolerated, or in whom dual antiplatelet therapy is desirable. (Wikipedia)
(2R,4S)-2-Aminoformyl-6-fluoro-spiro[chroman-4,4'-imidazolidine]-2',5'-dione
Fasentin
Fasentin, a potent glucose uptake inhibitor, inhibits GLUT-1/GLUT-4 transporters. Fasentin preferentially inhibits GLUT4 (IC50=68 μM) over GLUT1. Fasentin is a death receptor stimuli (FAS) sensitizer and sensitizes cells to FAS-induced cell death. Fasentin is also a tumor necrosis factor (TNF) apoptosis-inducing ligand sensitizer. Fasentin blocks glucose uptake in cancer cell lines and has anti-angiogenic activity[1][2][3].
Fexinidazole
C12H13N3O3S (279.06775880000004)
P - Antiparasitic products, insecticides and repellents > P01 - Antiprotozoals > P01C - Agents against leishmaniasis and trypanosomiasis > P01CA - Nitroimidazole derivatives C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent
Imepitoin
C78272 - Agent Affecting Nervous System > C264 - Anticonvulsant Agent Imepitoin (AWD 131-138) is a new low-affinity partial benzodiazepine receptor agonist with potent anticonvulsant and anxiolytic properties in rodent models.
Benzo(f)-1,3-benzodioxolo(6,5,4-cd)indol-5(6H)-one, 8-hydroxy-
Metolachlor CGA 357704
CONFIDENCE standard compound; INTERNAL_ID 2646 INTERNAL_ID 2646; CONFIDENCE standard compound
Sauristolactam
Sauristolactam is a natural product found in Saururus cernuus and Saururus chinensis with data available.
3-(2-amino-4,6-dioxo-3,4,5,6-tetrahydro-pteridin-7-yl)-2-oxo-propionic acid methyl ester|Erythropterin-methylester
Psicofuranine,1,4-Anhydro 79607-61-7
C11H13N5O4 (279.09674980000005)
(Xi)-7a,8-dihydro-5H,7H-benzo[g][1,3]dioxolo[4,5:4,5]benzo[1,2,3-de]quinolin-6-one|fuseine
2-Chloro-7-ethyl-6,8-dihydroxy-9H-pyrrolo[2,1-b][1,3]benzoxazine-9-one
penipanoid B
An alkaloid that is 3a,4-dihydroimidazo[1,5-a]quinazolin-5(3H)-one substituted by a 4-hydroxyphenyl group at position 3. It has been isolated from Penicillium paneum.
desulfo-1-methylpropyl GL|desulfoglucocochlearin|DS-GCC
10-Amino-2,4-dimethoxyphenanthrene-1-carboxylic acid lactam
Aristololactam IIIa
Aristololactam IIIa is a natural product found in Aristolochia debilis, Aristolochia kaempferi, and other organisms with data available.
Cepharanone B
Aristolactam BII is a natural product found in Piper arborescens, Piper augustum, and other organisms with data available.
ZLJ-6
C12H13N3O3S (279.06775880000004)
N-[4-hydroxy-(E)-cinnamoyl]-L-aspartic acid
5-amino-6-nitro-7-phenyl-2,3-dihydro-1H-indene-4-carbonitrile
2-amino-6-cyclopropyl-3-nitro-4-phenylbenzonitrile
1-CYCLOPROPYL-6,7-DIFLUORO-5-METHYL-4-OXO-3-QUINOLINE CARBOXYLIC ACID
2-CHLORO-1-(6-METHOXY-2,2,4-TRIMETHYL-2H-QUINOLIN-1-YL)-ETHANONE
3-[(2-NAPHTHYLSULFONYL)AMINO]PROPANOIC ACID
C13H13NO4S (279.05652580000003)
1H-Indole-1-acetamide,3-formyl-N-2-pyridinyl-(9CI)
2-Borono-4-fluoro-1H-indole-1-carboxylic acid 1-(1,1-dimethylethyl) ester
Benzoic acid, 4-[(3-formyl-1H-indol-1-yl)methyl]- (9CI)
Methyl 5,5,5-trifluoro-4-(4-fluorophenylamino)pentanoate
1-(4-CHLOROPHENYL)-3-MORPHOLINO-1H-PYRAZOL-5(4H)-ONE
sodium [3-(5-chloro-2-methoxyphenyl)-1-methyl-2-triazeno]acetate
C10H11ClN3NaO3 (279.03866059999996)
Decoyinine
C11H13N5O4 (279.09674980000005)
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents Decoyinine is a selective inhibitor of GMP synthetase (GMPS).
1-[3-chloro-5-(trifluoromethyl)-2-pyridyl]-1,4-diazepane
3-CARBOXYMETHYL-MORPHOLINE-4-CARBOXYLIC ACID BENZYL ESTER
tert-Butyl 2-amino-3-cyano-4,5-dihydrothieno[2,3-c]pyridine-6(7H)-carboxylate
4-[2-(chloromethyl)-4-(trifluoromethyl)phenyl]morpholine
6-BROMO-2-(PIPERIDIN-4-YL)-1H-BENZO[D]IMIDAZOLE
C12H14BrN3 (279.03710240000004)
diethyl 7-oxo-1H-pyrazolo[1,5-a]pyrimidine-3,6-dicarboxylate
METHYL 1-TOSYL-1H-PYRROLE-3-CARBOXYLATE
C13H13NO4S (279.05652580000003)
(2-amino-5-chlorophenyl)(2-fluoro-6-Methoxyphenyl)Methanone
3-BENZYL-4-OXO-3,4-DIHYDRO-PHTHALAZINE-1-CARBOXYLIC ACID AMIDE
Urea,N-(6-hydroxy-4,5,7-trimethyl-2-benzothiazolyl)-N,N-dimethyl-
3-CARBOXYMETHOXY-PYRROLIDINE-1-CARBOXYLIC ACID BENZYL ESTER
3-Nitro-6-[2-(triMethylsilyl)ethoxy]pyridine-2-acetonitrile
(s)-(+)-3-(benzyloxycarbonyl)-5-oxo-4-oxazolidineacetic acid
Acetamide,2-chloro-N-(2,3-dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)-
4-[4-Chloro-3-(trifluoromethyl)phenyl]-4-piperidinol
3-(4-FLUOROPHENYL)-3-(2,2,2-TRIFLUOROACETAMIDO)PROPANOIC ACID
6-Benzyl-2,4-dichloro-6,7-dihydro-5H-pyrrolo[3,4-d]pyrimidine
C13H11Cl2N3 (279.03299860000004)
2-Bromomethylmorpholine-4-carboxylic acid tert-butyl ester
(2-(BUTYLTHIO)-5-(TRIFLUOROMETHYL)PYRIDIN-3-YL)BORONIC ACID
C10H13BF3NO2S (279.07121040000004)
Methyl 4,6-O-Benzylidene-2-deoxy-alpha-D-erythro-hexopyranosid-3-ulose Oxime
3-Methanesulfonyloxymethyl-pyrrolidine-1-carboxylic acid tert butyl ester
Tetraethylazanium,trifluoromethanesulfonate
C9H20F3NO3S (279.11159260000005)
dimethylammonium 2-(2,4-dichlorophenoxy)propionate
3-benzylhydroxy-6-hydroxymethylpyridine-2-carboxaldehyde hydrochloride
C14H14ClNO3 (279.06621640000003)
NSC 207895
C11H13N5O4 (279.09674980000005)
NSC-207895 (XI-006), a DNA damaging agent, is an anticancer agent and p53 activator[1][2][3].
(2-(ISOBUTYLTHIO)-5-(TRIFLUOROMETHYL)PYRIDIN-3-YL)BORONIC ACID
C10H13BF3NO2S (279.07121040000004)
Acrylic acid-2-acrylamido-2-methyl propane sulfonic acid copolymer
C10H17NO6S (279.07765420000004)
It is used as a food additive .
5-amino-1,4-diphenyl-1H-pyrazole-3-carboxylic acid
2-AMINO-7-ISOPROPYL-5-OXO-5H-(1)BENZOPYRANO-(2,3-B)-PYRIDINE-3-CARBONITRILE
ethyl 4,6-dinitro-1H-indole-2-carboxylate
C11H9N3O6 (279.04913339999996)
TPCA-1
C12H10FN3O2S (279.04777320000005)
D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors
Benzeneacetamide,N-(3,4-dichlorophenyl)-
C14H11Cl2NO (279.02176560000004)
(R)-tert-Butyl 2-(bromomethyl)morpholine-4-carboxylate
(S)-tert-Butyl 2-(bromomethyl)morpholine-4-carboxylate
4-Chloro-6-ethoxyquinoline-3-carboxylic acid ethyl ester
C14H14ClNO3 (279.06621640000003)
2-(3-HYDROXY-PHENYL)-6-METHYL-QUINOLINE-4-CARBOXYLIC ACID
2-(2-Hydroxyphenyl)-6-methylquinoline-4-carboxylic acid
(S)-tert-butyl 3-(methylsulfonyloxy)piperidine-1-carboxylate
METHYL(2-NAPHTHYLSULFONYL)AMINO]ACETIC ACID
C13H13NO4S (279.05652580000003)
Letosteine
R - Respiratory system > R05 - Cough and cold preparations > R05C - Expectorants, excl. combinations with cough suppressants > R05CB - Mucolytics C78273 - Agent Affecting Respiratory System > C74536 - Mucolytic Agent D019141 - Respiratory System Agents > D005100 - Expectorants
(Z)-4-(4-METHOXYBENZYLIDENE)-2-PHENYLOXAZOL-5(4H)-ONE
Benzenemethanol, 2-chloro-a-[[(1,1-dimethylethyl)amino]methyl]-4-hydroxy-, hydrochloride (1:1)
(1R,2S,3S,5S)-METHYL 3-(4-CHLOROPHENYL)-8-AZABICYCLO[3.2.1]OCTANE-2-CARBOXYLATE
4-Nitrophenyl hydrogen phenylphosphonate
C12H10NO5P (279.02965800000004)
2-[1-(4-methylphenyl)sulfonylpyrrol-3-yl]acetic acid
C13H13NO4S (279.05652580000003)
(4-carbamoyl-3-hydroxy-isothiazol-5-yl)-carbamic acid phenyl ester
3-hydroxy-N-(3-hydroxyphenyl)naphthalene-2-carboxamide
[5-furan-2-yl-4-(2-methyl-allyl)-4 h-[1,2,4]triazol-3-ylsulfanyl]-acetic acid
C12H13N3O3S (279.06775880000004)
5-BROMOSPIRO[CYCLOHEXANE-1,3-INDOL]-2(1H)-ONE
C13H14BrNO (279.02586940000003)
7-PHENYL-1-(PROP-2-YNYL)-1H-PYRIMIDO[4,5-D][1,3]OXAZINE-2,4-DIONE
1-(3-BROMOPROPYL)-2,2,5,5-TETRAMETHYL-1-AZA-2,5-DISILACYCLOPENTANE
6-Bromo-2-[(2R)-2-pyrrolidinylmethyl]-1H-pyrrolo[2,3-b]pyridine
C12H14BrN3 (279.03710240000004)
6-Bromo-2-[(2S)-2-pyrrolidinylmethyl]-1H-pyrrolo[2,3-b]pyridine
C12H14BrN3 (279.03710240000004)
(1-(TERT-BUTOXYCARBONYL)-7-FLUORO-1H-INDOL-2-YL)BORONIC ACID
METHYL 4-AMINO-4-NAPHTHALEN-2-YL-BUTYRATE HYDROCHLORIDE
Cytarabine hydrochloride
C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C272 - Antimetabolite D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents D000890 - Anti-Infective Agents > D000998 - Antiviral Agents D009676 - Noxae > D000963 - Antimetabolites D000970 - Antineoplastic Agents Cytarabine hydrochloride, a nucleoside analog, causes S phase cell cycle arrest and inhibits DNA polymerase. Cytarabine inhibits DNA synthesis with an IC50 of 16 nM. Cytarabine hydrochloride has antiviral effects against HSV.
4-[(4-methoxyphenyl)methylidene]-2-phenyl-1,3-oxazol-5-one
2-(4-HYDROXY-PHENYL)-6-METHYL-QUINOLINE-4-CARBOXYLIC ACID
5-Bromo-2-[(2R)-2-pyrrolidinylmethyl]-1H-pyrrolo[2,3-b]pyridine
C12H14BrN3 (279.03710240000004)
1,5-DIPHENYL-1H-[1,2,4]TRIAZOLE-3-CARBOXYLIC ACID HYDRAZIDE
4-(4-fluorophenyl)sulfonylpiperidine,hydrochloride
C11H15ClFNO2S (279.04960120000004)
9H-Purine-9-acetic acid, 1,6-dihydro-2-(2-Methyl-1-oxopropyl)aMino-6-oxo-
C11H13N5O4 (279.09674980000005)
4-anilino-6-chloro-2-methylsulfanylpyrimidine-5-carbaldehyde
(+/-)-8,9-Difluoro-5-methyl-6,7-dihydro-1-oxo-1H,5H-bnezo[i,j]quinolizine-2-carboxylic acid
2-[3-cyano-4-(4-fluorophenyl)-5,5-dimethylfuran-2-ylidene]propanedinitrile
C16H10FN3O (279.08078620000003)
Phosphonic acid,P-(aminophenylmethyl)-, diethyl ester, hydrochloride (1:1)
2-(4-HYDROXYPHENYL)-3-METHYL-4-QUINOLINECARBOXYLIC ACID
4-(3-TRIFLUOROMETHYL-BENZYL)-PIPERIDINE HYDROCHLORIDE
C13H17ClF3N (279.10015480000004)
ETHYL 8-CHLORO[1,3]DIOXOLO[4,5-G]QUINOLINE-7-CARBOXYLATE
5-(4-BROMO-PHENYL)-2-ISOPROPYL-2H-PYRAZOL-3-YLAMINE
C12H14BrN3 (279.03710240000004)
2-Fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)Methyl)benzonitrile
C16H10FN3O (279.08078620000003)
(Z)-4-(2-METHOXYBENZYLIDENE)-2-PHENYLOXAZOL-5(4H)-ONE
2-(4-METHOXYBENZOYL)-3,3-DI(METHYLTHIO)ACRYLONITRILE
ETHYL 8-CHLORO-1-ETHYL-4-OXO-4H-QUINOLIZINE-3-CARBOXYLATE
C14H14ClNO3 (279.06621640000003)
tert-Butyl 4-((methylsulfonyl)oxy)piperidine-1-carboxylate
Potassium (S)-5-(tert-butoxycarbonyl)-5-azaspiro[2.4]heptane-6-carboxylate
methyl 1-cyclopropyl-6,7-difluoro-4-oxo-1,4-dihydroquinoline-3-carboxylate
(3S,4S,5S,6R)-2-(Hydroxymethyl)-6-(1H-indol-1-yl)-tetrahydro-2H-pyran-3,4,5-triol
2-Amino-5-beta-D-ribofuranosyl-4(1H)-pyrimidinone hydrochloride
Ethyl 2-amino-4-(4-fluorophenyl)-5-methyl-thiophene-3-carboxylate
3-Quinolinecarbonitrile,2-amino-6-chloro-4-phenyl-
1-[2-(Trimethylsilyl)ethoxycarbonyloxy]benzotriazole
6-Bromo-2-isopropoxy-4-methylquinoline
C13H14BrNO (279.02586940000003)
4-Formyl-1-methylpyridinium benzenesulfonate
C13H13NO4S (279.05652580000003)
3-[Dimethyl-[2-(2-methylprop-2-enoyloxy)ethyl]azaniumyl]propane-1-sulfonate
2-(piperidin-1-ylmethyl)-1H-quinazolin-4-one,hydrochloride
5-amino-2-(4-aminoanilino)benzenesulfonic acid
C12H13N3O3S (279.06775880000004)
METHYL 4-AMINO-4-NAPHTHALEN-1-YL-BUTYRATE HYDROCHLORIDE
4-(benzo[1,3]dioxol-5-ylcarbamoyl)-3,3-dimethyl-butyric acid
4-(phenylmethoxycarbonylamino)oxane-4-carboxylic acid
(5-NITRO-1,2-BENZISOXAZOL-3-YL)CARBAMIC ACID 1,1-DIMETHYL ETHYL ESTER
3-(3-Fluoro-4-hydroxyphenyl)-7-hydroxy-1-naphthonitrile
C17H10FNO2 (279.06955320000003)
3-chloro-2,2-dimethyl-N-[4-(trifluoromethyl)phenyl]propanamide
N-[2-chloro-5-(trifluoromethyl)phenyl]imidodicarbonimidic diamide
C9H9ClF3N5 (279.04985400000004)
Taribavirin hydrochloride
D000890 - Anti-Infective Agents > D000998 - Antiviral Agents C254 - Anti-Infective Agent > C281 - Antiviral Agent
5-[(2-Chlorophenyl)methyl]-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-7-ol
6-Fluoro-2,5-dioxo-2,3-dihydrospiro[chromene-4,4-imidazolidine]-2-carboxamide
5-(2-Furanylmethylamino)-2-(3-methylphenyl)-4-oxazolecarbonitrile
[2-(2,3-Dimethoxyphenyl)-1,3-thiazol-4-yl]acetic acid
C13H13NO4S (279.05652580000003)
1-(6-methyl-2-pyridinyl)-N-(3-pyridinyl)-4-imidazolecarboxamide
4-[(4-phenoxyanilino)methylidene]-1H-pyrazol-5-one
N-[5-(methylthio)-1,3,4-thiadiazol-2-yl]-3-phenylpropanamide
Benzophenone, 2,5-dichloro-2-methylamino-
C14H11Cl2NO (279.02176560000004)
Dimethyl 2-[[bis(methylsulfanyl)methylideneamino]methyl]butanedioate
(2S,4R)-2-Aminoformyl-6-fluoro-spiro[chroman-4,4-imidazolidine]-2,5-dione
2-[(5-Hex-1-Yn-1-Ylfuran-2-Yl)carbonyl]-N-Methylhydrazinecarbothioamide
But-3-enyl-[5-(4-chloro-phenyl)-3,6-dihydro-[1,3,4]thiadiazin-2-ylidene]-amine
[(1S)-4-[[Amino-[(2R)-2-amino-2-carboxyethyl]sulfanylmethylidene]amino]-1-carboxybutyl]azanium
Fexinidazole
C12H13N3O3S (279.06775880000004)
P - Antiparasitic products, insecticides and repellents > P01 - Antiprotozoals > P01C - Agents against leishmaniasis and trypanosomiasis > P01CA - Nitroimidazole derivatives C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent
(3S)-3-azaniumyl-4-[[(1S)-1-carboxylato-2-phenylethyl]amino]-4-oxobutanoate
(2S)-5-amino-5-oxo-2-(phenylmethoxycarbonylamino)pentanoate
2-[4-(Trifluoromethoxy)phenyl]imidazo[1,2-a]pyrimidine
N-[5-(ethylthio)-1,3,4-thiadiazol-2-yl]-4-methylbenzamide
4-(2-Pyridinylthio)benzofuro[3,2-d]pyrimidine
C15H9N3OS (279.04663039999997)
2-[(3-Methoxyphenyl)-oxomethyl]-3,3-bis(methylthio)-2-propenenitrile
4-amino-3-methyl-N-(phenylmethyl)-2-sulfanylidene-5-thiazolecarboxamide
O3-(3-chlorobenzoyl)-5-methylisoxazole-3-carbohydroximamide
N-(1,3-benzodioxol-5-yl)-4-methylphthalazin-1-amine
2-[2-(Butan-2-ylidene)hydrazino]-4-(4-chlorophenyl)-1,3-thiazole
5-(2-Furanylmethylamino)-2-(2-methylphenyl)-4-oxazolecarbonitrile
2-Hydroxy-4-methoxybenzoic acid (2-methyl-4-thiazolyl)methyl ester
C13H13NO4S (279.05652580000003)
7-[(2,6-Dimethyl-4-morpholinyl)methyl]-5-thiazolo[3,2-a]pyrimidinone
5-(4-Hydroxy-3-nitrobenzylidene)-3-methyl-2-thioxo-4-imidazolidinone
(5Z)-5-(1-naphthylmethylene)[1,3]thiazolo[3,2-b][1,2,4]triazol-6(5H)-one
C15H9N3OS (279.04663039999997)
2-methoxy-N-methyl-N-[5-(5-methyl-2-pyrazinyl)-1,3,4-thiadiazol-2-yl]acetamide
C11H13N5O2S (279.07899180000004)
1-S-(N-hydroxybut-3-enimidoyl)-1-thio-beta-D-glucopyranose
C10H17NO6S (279.07765420000004)
1-Octanoyl-sn-glycero-2,3-cyclic phosphate
C11H20O6P- (279.09974500000004)
[5-(4-chlorophenyl)-1-isopropyl-1H-1,2,4-triazol-3-yl]acetic acid
4H-3,1-Benzoxazin-4-one, 2-(2-(3-methoxyphenyl)ethenyl)-
3-Chloro-4-[(2-fluorophenyl)methoxy]benzaldehyde oxime
3-[[(2,3-Dihydro-2,2-dimethyl-7-benzofuranyloxy)carbonyl]-amino]propanoic acid
2-Chloro-3-(3-methoxypropylimino)naphthalene-1,4-dione
C14H14ClNO3 (279.06621640000003)
6-Chloro-3-(3,3-dimethyl-2-oxobutyl)-1,4-benzoxazin-2-one
C14H14ClNO3 (279.06621640000003)
6-Chloro-3-(4-methyl-2-oxopentyl)-1,4-benzoxazin-2-one
C14H14ClNO3 (279.06621640000003)
2-Chloro-4-quinolinecarboxylic acid trimethylsilyl ester
5-Acetoxy-3-[(diethoxyphosphinyl)methyl]-2-isoxazoline
3-[(Diethoxyphosphinyl)methyl]-5-methoxycarbonyl-2-isoxazoline
Cidofovir
J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals > J05AB - Nucleosides and nucleotides excl. reverse transcriptase inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents C471 - Enzyme Inhibitor > C29575 - DNA Polymerase Inhibitor C254 - Anti-Infective Agent > C281 - Antiviral Agent D004791 - Enzyme Inhibitors
7-Hydroxyticlopidine
A thienopyridine that is ticlopidine which carries a hydroxy group at position 7. It is a metabolite of the antiplatelet drug, ticlopidine.
6-bromoconicamin
A bromoindole that is 1H-indole substituted by 2-(trimethylazaniumyl)ethenyl and bromo groups at positions 3 and 6, respectively. It is isolated from the marine sponge Geodia barretti.
N-(beta-D-glucopyranosyl)indole
An N-glycosyl compound that is 1H-indole in which the hydrogen attached to the nitrogen has been replaced by a beta-D-glucosyl group. A (non-fluorescent) constituent of the death fluorescence compounds of C. elegans. SMID ID: iglu#1.
desulfosinigrin
C10H17NO6S (279.07765420000004)
A desulfoglucosinolic acid resulting from the formal condensation of the thiol group of N-hydroxybut-3-enethioamide with beta-D-glucopyranose.
2'-O,4'-C-Methyleneadenosine
C11H13N5O4 (279.09674980000005)
2'-O,4'-C-Methyleneadenosine (LNA-A) is a locked nucleic acid (LNA) and is also an adenosine analog[1].
5-HT3 antagonist 5
5-HT3 antagonist 5 is a quinoxalin-2-carboxamide compound, a 5-HT3 receptor antagonist. 5-HT3 antagonist 5 exerts antagonism on 5-HT3 agonist and 2-methyl-5-HT, and shows anti-depressant effect in mice[1].
Agomelatine (hydrochloride)
Agomelatine hydrochloride (S-20098 hydrochloride) is a specific agonist of MT1 and MT2 receptors with Kis of 0.1, 0.06, 0.12, and 0.27 nM for CHO-hMT1, HEK-hMT1, CHO-hMT2, and HEK-hMT2, respectively[1]. Agomelatine hydrochloride is a selective 5-HT2C receptor antagonist with pKis of 6.4 and 6.2 at native (porcine) and cloned, human 5-HT2C receptors, respectively[2].
UCM-1306
UCM-1306 is a potent and orally active human dopamine D1 receptor allosteric modulator (PAM). UCM-1306 increases the endogenous dopamine (DA) maximal effect both in human and mouse D1 receptors. UCM-1306 is not only for improving motor symptoms but also for addressing the key comorbid cognitive impairment associated with long-term Parkinson’s disease (PD)[1].
(9s)-15-hydroxy-16-methoxy-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2,4,6,11,13,15-heptaen-8-one
(10z,12z)-7,16-dihydroxy-11-azatricyclo[12.4.0.0⁴,⁹]octadeca-1(18),4,6,8,10,12,14,16-octaen-2-one
10-hydroxy-3-methoxy-4-methylidene-11-[(1e)-prop-1-en-1-yl]-6-oxa-3-azatricyclo[5.3.1.0¹,⁵]undecane-2,9-dione
15-hydroxy-16-methoxy-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2,4,6,11,13,15-heptaen-8-one
(12s)-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8(20),14,16,18-hexaen-13-one
2-{2-[1-(carboxymethylcarbamoyl)ethylidene]hydrazin-1-yl}benzoic acid
10-amino-2,4-dimethoxyphenanthrene-1-carboxylicacid lactam
{"Ingredient_id": "HBIN000055","Ingredient_name": "10-amino-2,4-dimethoxyphenanthrene-1-carboxylicacid lactam","Alias": "NA","Ingredient_formula": "C17H13NO3","Ingredient_Smile": "COC1=CC(=C2C3=C1C4=CC=CC=C4C=C3NC2=O)OC","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "1049","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
10-amino-2,4-dimethoxyphenanthrene-1carboxylie acid lactam
{"Ingredient_id": "HBIN000056","Ingredient_name": "10-amino-2,4-dimethoxyphenanthrene-1carboxylie acid lactam","Alias": "NA","Ingredient_formula": "C17H13NO3","Ingredient_Smile": "COC1=CC(=C2C3=C1C4=CC=CC=C4C=C3NC2=O)OC","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "25598","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
10-amino-3,6-dihydroxy-2,4-dimethoxyphenanthrene-1-carboxylic acid lactam
{"Ingredient_id": "HBIN000057","Ingredient_name": "10-amino-3,6-dihydroxy-2,4-dimethoxyphenanthrene-1-carboxylic acid lactam","Alias": "NA","Ingredient_formula": "C17H13NO3","Ingredient_Smile": "COC1=CC(=C2C3=C1C4=CC=CC=C4C=C3NC2=O)OC","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "41696","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
4-hydroxy-3-methoxy-n-methylaristolactam
{"Ingredient_id": "HBIN010478","Ingredient_name": "4-hydroxy-3-methoxy-n-methylaristolactam","Alias": "NA","Ingredient_formula": "C17H13NO3","Ingredient_Smile": "CN1C2=CC3=CC=CC=C3C4=C2C(=CC(=C4O)OC)C1=O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10415","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
aristolactam i; o-de-me
{"Ingredient_id": "HBIN016781","Ingredient_name": "aristolactam i; o-de-me","Alias": "NA","Ingredient_formula": "C16H9NO4","Ingredient_Smile": "NA","Ingredient_weight": "279.25","OB_score": "NA","CAS_id": "85814-30-8","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "6669","PubChem_id": "NA","DrugBank_id": "NA"}
(4r,6r,10e)-4,6-dihydroxy-2-methoxy-3-methylidene-10-propylidene-2-azaspiro[4.5]dec-8-ene-1,7-dione
9-hydroxy-5,7-dioxa-12-azapentacyclo[10.6.1.0²,¹⁰.0⁴,⁸.0¹⁵,¹⁹]nonadeca-1(19),2(10),3,8,13,15,17-heptaen-11-one
10-hydroxy-3-methoxy-4-methylidene-11-(prop-1-en-1-yl)-6-oxa-3-azatricyclo[5.3.1.0¹,⁵]undecane-2,9-dione
(10e,12z)-7,16-dihydroxy-11-azatricyclo[12.4.0.0⁴,⁹]octadeca-1(18),4,6,8,10,12,14,16-octaen-2-one
3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8(20),10,14,16,18-heptaen-10-ol
(4r,5s,6s,10z)-4,6-dihydroxy-2-methoxy-3-methylidene-10-propylidene-2-azaspiro[4.5]dec-8-ene-1,7-dione
4,5-dimethoxy-9-azatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(15),2(7),3,5,10,12(16),13-heptaen-8-one
(3s,3as)-3-(4-hydroxyphenyl)-3h,3ah-imidazo[1,5-a]quinazolin-5-ol
2-{[1-hydroxy-3-(4-hydroxyphenyl)prop-2-en-1-ylidene]amino}butanedioic acid
(2s,3r,4s,5s,6r)-2-{[1-(hydroxyimino)but-3-en-1-yl]sulfanyl}-6-(hydroxymethyl)oxane-3,4,5-triol
C10H17NO6S (279.07765420000004)
(2'e)-6'-hydroxy-4-methoxy-5-methyl-2'-propylidene-6-oxa-4-azaspiro[bicyclo[3.1.0]hexane-2,1'-cyclohexan]-3'-ene-3,5'-dione
3-(4-hydroxyphenyl)-3h,3ah-imidazo[1,5-a]quinazolin-5-ol
10-amino-9-chloro-2-methyl-3-(methylsulfanyl)-2,7-diazatricyclo[6.3.1.0⁴,¹²]dodeca-1(12),3,5,7,9-pentaen-11-one
7,8-dimethoxy-2-azatetracyclo[7.6.1.0⁵,¹⁶.0¹⁰,¹⁵]hexadeca-1(16),2,4,6,8,10,12,14-octaen-13-ol
14-hydroxy-15-methoxy-10-methyl-10-azatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),2(7),3,5,8,12,14-heptaen-11-one
(4r,5s,10e)-4,6-dihydroxy-2-methoxy-3-methylidene-10-propylidene-2-azaspiro[4.5]dec-8-ene-1,7-dione
(1r,2r,2'z,5r,6's)-6'-hydroxy-4-methoxy-5-methyl-2'-propylidene-6-oxa-4-azaspiro[bicyclo[3.1.0]hexane-2,1'-cyclohexan]-3'-ene-3,5'-dione
3,5-dioxa-10-azapentacyclo[9.7.1.0²,⁶.0⁸,¹⁹.0¹³,¹⁸]nonadeca-1(19),2(6),7,9,11,13(18),14,16-octaene-7,9-diol
7,8-dimethoxy-2-azatetracyclo[7.6.1.0⁵,¹⁶.0¹⁰,¹⁵]hexadeca-1(16),2,4,6,8,10,12,14-octaen-11-ol
4,6-dihydroxy-2-methoxy-3-methylidene-10-[(1e)-prop-1-en-1-yl]-2-azaspiro[4.5]dec-8-ene-1,7-dione
4-{2h-[1,3]dioxolo[4,5-g]isoquinolin-5-ylmethyl}phenol
(5r,6r,9r,10r)-9,10-dihydroxy-2-methoxy-3-methylidene-6-[(1e)-prop-1-en-1-yl]-2-azaspiro[4.5]dec-7-ene-1,4-dione
3,5-dioxa-10-azapentacyclo[9.7.1.0²,⁶.0⁸,¹⁹.0¹³,¹⁸]nonadeca-1(19),2(6),7,9,11,13(18),14,16-octaene-9,16-diol
(1r,5r,7r,10s,11r)-10-hydroxy-3-methoxy-4-methylidene-11-[(1e)-prop-1-en-1-yl]-6-oxa-3-azatricyclo[5.3.1.0¹,⁵]undecane-2,9-dione
(2s,3r,4s)-3,4-dihydroxy-6-methoxy-7-methylidene-2-[(1e,3e)-penta-1,3-dien-1-yl]-2h,3h,4h-pyrano[2,3-c]pyrrol-5-one
(2r)-2-{[(2e)-1-hydroxy-3-(4-hydroxyphenyl)prop-2-en-1-ylidene]amino}butanedioic acid
(1s,5s,7r,10s,11s)-10-hydroxy-3-methoxy-4-methylidene-11-[(1e)-prop-1-en-1-yl]-6-oxa-3-azatricyclo[5.3.1.0¹,⁵]undecane-2,9-dione
6'-hydroxy-4-methoxy-5-methyl-2'-propylidene-6-oxa-4-azaspiro[bicyclo[3.1.0]hexane-2,1'-cyclohexan]-3'-ene-3,5'-dione
(12e)-7,16-dihydroxy-11-azatricyclo[12.4.0.0⁴,⁹]octadeca-1(18),4,6,8,10,12,14,16-octaen-2-one
9,10-dihydroxy-2-methoxy-3-methylidene-6-(prop-1-en-1-yl)-2-azaspiro[4.5]dec-7-ene-1,4-dione
(4s,5r,6r,10z)-4,6-dihydroxy-2-methoxy-3-methylidene-10-propylidene-2-azaspiro[4.5]dec-8-ene-1,7-dione
2-(4-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}phenyl)acetonitrile
(2r,3r,4s)-2-(6-aminopurin-9-yl)-2-(hydroxymethyl)-5-methylideneoxolane-3,4-diol
C11H13N5O4 (279.09674980000005)